China’s benchmark Shanghai Composite Index (000001.SH) gained 0.58% on Monday, while the Shenzhen Component Index (399001.SZ) rose 0.72%.
Shanghai’s tech-heavy STAR 50 Index (000688.SH) lost 0.24% for the day, while Shenzhen’s similar ChiNext Index (399006.SZ) rose 0.75%.
Below is a rundown of the top China business and finance stories, plus other news for the day:
· Cover Story: China’s International Air Travel Resumes, But Covid Turbulence to Delay Takeoff
Airlines are struggling with understaffing and a new strain of the virus threatens to slow recovery in what was the world’s largest outbound travel market
· China Wraps Up Two-Year Tech Crackdown, Top Official Says
Central bank and banking regulator’s Guo Shuqing sends first signal that sector led by Alibaba, Tencent, Didi and Meituan may finally be off the hook
· China to De-Criminalize Violations of Covid Containment Rules
Supreme People’s Court joined other judiciary organs in also ordering the release of those detained and awaiting trial under the now defunct ‘zero-Covid’ policy
· Chinese Property Developers Get Year-End Financing Boost, Consultancy Says
The top 100 companies saw financing jump almost 85% in December as the government relaxed curbs to ease a liquidity crunch, according to CRIC
· Weekend Long Read: Covid Is Rife at China’s Colleges. Exams Are Going Ahead Anyway
For months, China’s students have prepared under harsh ‘zero-Covid’ restrictions. Now, many have to take crucial tests while infected with the virus
· Central Bank Fines Three Financial Institutions $19.5 Million
China Merchants Bank, China Guangfa Bank and China UnionPay unit punished for violations in payment and clearing businesses
· Chinese Mainlanders Can Book Omicron-Specific mRNA Shot in Hong Kong
Fosun Pharma opens online reservation platform for BioNTech vaccination as Covid border controls are set to end
· China to End Quarantine for Crews on International Flights
Regulators will also drop a requirement for airline staff to wear protective gear while abroad
· Analysis: China’s Limits on Dispensing Pfizer’s Paxlovid Could Delay Treatment
Limited supplies of the highly sought-after antiviral drug used to treat Covid has prompted tough restrictions to be imposed on buyers, raising concerns that those in urgent need could face delays
· Hong Kong Greenlights 1,400 Visas in Drive to Lure Skilled Professionals
The Top Talent Pass Scheme has received about 2,600 applicants within a week of its launch
Click here to read more of the latest news.
This article was generated by Caixin Automation.
Follow the Chinese markets in real time with Caixin Global’s new stock database.
